Improving diagnosis and treatment of diabetic retinopathy in type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study integrates clinical indicators and fundus image features with metabolomics to create an early warning model for diabetic retinopathy (DR) in patients with type 2 diabetes. It aims to establish a precise DR typing model based on the age of diabetes onset and the presence of diabetic macrovascular complications. A multidisciplinary approach will be employed for comprehensive management of moderate-stage DR, utilizing cloud-based patient rooms and continuous glucose monitoring to enhance patient care. The goal is to pioneer a new management model for advanced DR.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Meets the diagnostic criteria for type 2 diabetes in the "China Type 2 Diabetes Prevention and Treatment Guidelines (2020 Edition)";

  * Aged between 20 and 79 years old, without other severe underlying diseases; ③ Possesses full cognitive and literacy abilities; ④ Volunteers to participate in this study and are willing to sign an informed consent form.

Exclusion Criteria:

* Those who have been diagnosed with type 1 or other types of diabetes;

  * Those with severe cardiac, pulmonary, hepatic, or renal insufficiency;

    * Those with mental confusion, speech disorders, or dementia, etc.;

      * Those who are unable to take care of themselves, bedridden, or have mobility impairments; ⑤ Women who are breastfeeding or pregnant;

        * Those with a recent history of surgery, trauma, acute major vascular complications, or infectious diseases.

Where it's running

• The first hosptial of lanzhou university
  Lanzhou, China Recruiting
• Shanghai general hosptial
  Shanghai, China Recruiting
• The forth people's hosptial of shenyang
  Shenyang, China Recruiting

Study contacts

• Study coordinator: Liping Gu Liping Gu
• Email: guliping1980@126.com
• Phone: 86-13564720656

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes

  This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.

  Recruiting at 3 sites Steno Diabetes Center Copenhagen · Copenhagen and 2 other locations · NCT07250789

• Using AI Chatbots to Help Diabetic Patients

  This study tests whether AI chatbots can help people with diabetes by giving them useful information on diet, stress management, and weight control, and compares their experiences with and without human support.

  Recruiting Pakistan Council of Scientific and Industrial Research · Karachi, Sindh · NCT05883072

• Lifestyle change program to help type 2 diabetes go into remission in Pakistan

  This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.

  Recruiting at 2 sites Green International University · Lahore, Punjab Province and 1 other locations · NCT07912944

• Corticosteroid for Diabetic Macular Edema (DME) in Adults with Diabetic Retinopathy

  This trial tests whether intravitreal corticosteroid injections can influence inflammatory biomarkers and improve DME in adults with type 2 diabetes.

  Recruiting Phase 4 Vanderbilt University Medical Center · Nashville, Tennessee · NCT07843849

• New virtual care pathway for older adults with chronic diseases

  A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.

  Recruiting National University of Malaysia · Kuala Lumpur · NCT07843238

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.